DeCure's autonomous Rare AI scientist is researching a drug-repurposing hypothesis for synovitis — screening already-approved drugs against its 5-gene Open Targets disease module to publish open-access research. Research is fast; the path to publication is funded in milestone stages.
Disease moduleSynovitis maps to a 5-gene Open Targets module — the target space DeCure's AI scientist screens approved drugs against.
DeCure.ai methodSignature reversal (LINCS) plus network proximity (STRING) rank already-approved drugs likely to perturb this module — the same engine that produces DeCure.ai's repurposing hypotheses.
Repurposing thesisScreening approved medicines against this disease module, then publishing the evidence for the strongest candidate. Known pharmacology and human exposure data make the first question sharper — they do not establish safety or efficacy in a new indication.
Research record
01
ResearchComing soon
Candidate research + dossier — target rationale, drug-repurposing thesis and evidence pack.proof: Published dossier + on-chain hash
02
ValidationComing soon
In-vitro biological validation at a contract research org (CRO).proof: CRO contract + in-vitro report
03
Peer review & paperComing soon
Peer-reviewed paper published open-access (preprint + journal).proof: DOI + open-access link + on-chain hash
Current lead
No approved-drug candidate for synovitis is corroborated in the literature DeepSearch retrieved. Some conditions are managed with non-pharmacological care — a device, surgery or physical therapy — rather than a medicine; that may be the case here, or the literature we found may simply be too sparse yet to support a drug-repurposing angle.
Molecular view
nuclear receptor subfamily 3 group C member 1 (NR3C1) — NR3C1 is one of the genes genetically linked to this disease in Open Targets — shown as context, not as a drug target we're pursuing: no approved-drug candidate for this disease is yet corroborated in the literature we found.
Loading structure…
helix sheet adpdrag to rotate · scroll to zoom
RCSB Protein Data Bank · entry 7KW7 · 3.57 Å · ligand ADENOSINE-5'-DIPHOSPHATE (ADP). Experimental structure, not a prediction.
What the evidence adds up to
In a 2005 study of 35 subjects with clinically diagnosed knee osteoarthritis, semiquantitative MRI scoring of synovitis on a 0–3 scale was compared with detailed volume measurements at four joint sites. Correlations between the simple scores and volume measurements ranged from rho = 0.86 for the medial parapatellar recess to rho = 0.71 for the lateral parapatellar recess. Ordinal regression showed that the semiquantitative scores predicted between 50% and 70% of the volume measurements (R² = 0.53 to R² = 0.71), though some overlap occurred in the mid-range scores. The authors concluded that semiquantitative synovitis scores are valid for feasible evaluation of the synovium in osteoarthritis cohorts.
A 2017 paper described the development of an antigen-induced synovitis model in Large White pigs. Pre-immunised pigs were used to evaluate the model, and immune monitoring of synovial fluid identified IL-12p40 and T cell subsets as immune biomarkers. The evolution of synovitis was assessed by arthroscopic procedures and kinetic analysis. The authors presented this as a clinically relevant animal model for evaluating anti-inflammatory therapies, but no therapeutic agents were tested in the study itself.
A 2013 study reported on 17 patients (mean age 42.5 years) with chronic nonspecific synovitis of the knee resistant to medical treatment. All patients underwent surgical synovectomy followed six weeks later by radiation synovectomy with yttrium-90. After a mean follow-up of 48.7 months, all patients rated their satisfaction as excellent or very good. The Lysholm Knee Scale scores and visual analog scale scores for nocturnal pain, resting pain, activity pain, and effusion all showed statistically significant improvement after treatment. No radionuclide leakage was detected on control scintigraphy. One case of deep vein thrombosis occurred. The authors concluded that the combined procedure is effective and safe for recurrent chronic nonspecific synovitis.
What remains missing is any randomised controlled trial comparing this combined surgical and radiation approach to either treatment alone, or to non-surgical options. The animal model paper did not test any drug. The MRI validation study did not address treatment. No data exist on which patient subgroups might benefit most, and no funding for a larger, blinded trial has been reported.
Evidence
Retrieved by DeepSearch across 234,678,978 indexed works and resolved on OpenAlex — ranked by citations, including the results that did not work.
Lara D. Veeken · 2005 · 70 citations
The validation of simple scoring methods for evaluating compartment-specific synovitis detected by MRI in knee osteoarthritis
AbstractOBJECTIVES: Synovitis is common in osteoarthritis (OA) of the knee. In order to evaluate its importance, valid and reliable quantification methods are required. The aim of this study was to compare simple, semiquantitative synovitis scores with detailed volume assessments in subjects with knee OA using magnetic resonance imaging (MRI) as the investigative tool. METHODS: Thirty-five subjects with clinically diagnosed OA of the knee were assessed for synovitis using gadolinium-enhanced MRI. The volume measurement of synovitis was assessed at four sites (medial and lateral parapatellar recesses, intercondylar notch and suprapatellar pouch). The semiquantitative scoring of synovitis was scored on a 0-3 scale. Establishment of a correlative relationship was undertaken using Spearman's rho for the individual site-specific measurements. Ordinal regression modelling was undertaken in order to establish the capacity of the synovitis scoring to predict the volume measurement. RESULTS: A total of 140 sites were assessed. There were good correlations between the semiquantitative scores and the volume measurements, ranging from rho = 0.86 (P < 0.00) for the medial parapatellar recess to rho = 0.71 (P < 0.00) for the lateral parapatellar recess. The ordinal regression suggested that, while the synovitis scores predicted between 50 and 70% (R2 = 0.53, P < 0.00 to R2 = 0.71, P < 0.00) of the volume measurements, there was some minor overlap, particularly in the mid-range synovitis scores. CONCLUSIONS: These results suggest that semiquantitative synovitis scores are valid and will enable feasible evaluation of the synovium in OA cohorts.
BMC Veterinary Research · 2017 · 3 citations · open access
Evaluation of antigen-induced synovitis in a porcine model: Immunological, arthroscopic and kinetic studies
AbstractBACKGROUND: Synovitis is an inflammation-related disease linked to rheumatoid arthritis, osteoarthritis, infections and trauma. This inflammation is accompanied by immune cells infiltration which initiates an inflammatory response causing pain, discomfort and affecting the normal joint function. The treatment of synovitis is based on the administration of anti-inflammatory drugs or biological agents such as platelet rich plasma and mesenchymal stem cells. However, the evaluation and validation of more effective therapies of synovitis requires the establishment of clinically relevant animal models. RESULTS: In this study, Large White pigs were pre-immunized to evaluate an antigen-induced synovitis. The immune monitoring of synovial fluids in this model allowed us the identification of IL-12p40 and T cell subsets as immune biomarkers. Moreover, the evolution of synovitis was performed by arthroscopic procedures and kinetic analysis. In summary, this paper describes an animal model of antigen-induced synovitis to be used in the evaluation of anti-inflammatory therapies. CONCLUSIONS: The novelty of this paper lies in the development of a clinically relevant model of synovitis which permits the simultaneous evaluation of synovitis from an immunological, surgical and kinetic point of view.
Joint Diseases and Related Surgery · 2013 · 0 citations · open access
Radiation synovectomy therapy combined with surgical synovectomy in chronic nonspecific synovitis of the knee joint
AbstractOBJECTIVES: This study aims to investigate the effectiveness of the radiation synovectomy (RS) procedure combined with the surgical synovectomy in the treatment of chronic nonspecific synovitis, which are resistant to medical treatment. PATIENTS AND METHODS: Between March 2004 and October 2009, 17 knees of the 17 patients (15 males, 2 females; mean age 42.5 years; range 27 to 70 years) who underwent synovectomy surgery, followed by RS procedure with the 90Y at six weeks were included. At the end of a mean 48.7 months (range; 15-126 months) follow-up period, the Lysholm Knee Scale scores were used for functional assessment before and after RS procedure. The nocturnal pain, resting pain, activity pain and effusion were evaluated with the visual analog scale. The patient satisfaction was recorded as excellent, very good, good and poor. RESULTS: At the end of the follow-up period, all patients had satisfaction scores of excellent and very good. There was a statistically significant difference between all assessment scores before and after treatment (p<0.05). It was found that none of the cases had radionuclide leakage from the joint in their control scintigraphy following RS procedure. No significant complication was seen except for deep vein thrombosis developed in one case. CONCLUSION: Our study results showed that RS procedure combined with the surgical synovectomy is an effective and safe treatment method for the treatment of cases of chronic nonspecific synovitis which recurs despite medical treatment.
Disease module: DeepOracle (Open Targets). Structures: RDKit from PubChem SMILES. Literature: retrieved by DeepSearch across 234,678,978 indexed works (targeted per-candidate search), resolved on OpenAlex.
DeCure is a research and publication project, not medical advice and not a treatment. "DeCure for X" describes a research goal, not a claim that a cure exists. Backing a cure is a contribution to fund the research — it is not an investment, and confers no yield, royalty, equity or IP ownership. Papers are published open-access by the DeCure.ai DAO.
